Safety of simultaneous bilateral intravitreal versus unilateral anti-vasculo-endothelial growth factors injection in an operating room setting

HIGHLIGHTS

• who: Irfan Kabiruddin Jeeva and collaborators from the This retrospective study was carried out at Aga Khan University Hospital Karachi, PakistanApproval was taken from the institute`s Ethical Review Committee (ERC) prior to the study for retrospective review of data. As it was a retrospective review the ERC waived full review (ERC #:, Date:, th August, ). The study employed a cross sectional design. Patients were identified using the hospital electronic coding system by using convenience sampling. Data for all patients was obtained from the medical records. Those patients who had received aflibercept, bevacizumab and/or ranibizumab in the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.